[go: up one dir, main page]

FR2799465B1 - Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire - Google Patents

Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire

Info

Publication number
FR2799465B1
FR2799465B1 FR9912714A FR9912714A FR2799465B1 FR 2799465 B1 FR2799465 B1 FR 2799465B1 FR 9912714 A FR9912714 A FR 9912714A FR 9912714 A FR9912714 A FR 9912714A FR 2799465 B1 FR2799465 B1 FR 2799465B1
Authority
FR
France
Prior art keywords
peptides
activity
immune response
tissue regeneration
stimulate immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9912714A
Other languages
English (en)
Other versions
FR2799465A1 (fr
Inventor
Denis Barritault
Ammar Achour
Jose Courty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9912714A priority Critical patent/FR2799465B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to CA002387604A priority patent/CA2387604A1/fr
Priority to PCT/FR2000/002786 priority patent/WO2001027136A2/fr
Priority to JP2001530354A priority patent/JP2004502636A/ja
Priority to AU77955/00A priority patent/AU7795500A/en
Priority to EP00967971A priority patent/EP1222201A2/fr
Publication of FR2799465A1 publication Critical patent/FR2799465A1/fr
Priority to US10/116,391 priority patent/US6932973B2/en
Application granted granted Critical
Publication of FR2799465B1 publication Critical patent/FR2799465B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR9912714A 1999-10-12 1999-10-12 Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire Expired - Fee Related FR2799465B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9912714A FR2799465B1 (fr) 1999-10-12 1999-10-12 Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
PCT/FR2000/002786 WO2001027136A2 (fr) 1999-10-12 2000-10-06 Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
JP2001530354A JP2004502636A (ja) 1999-10-12 2000-10-06 免疫応答及び組織の再生を活性化するペプチド
AU77955/00A AU7795500A (en) 1999-10-12 2000-10-06 Peptides which stimulate the immune response and tissue regeneration
CA002387604A CA2387604A1 (fr) 1999-10-12 2000-10-06 Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
EP00967971A EP1222201A2 (fr) 1999-10-12 2000-10-06 Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
US10/116,391 US6932973B2 (en) 1999-10-12 2002-04-04 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9912714A FR2799465B1 (fr) 1999-10-12 1999-10-12 Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire

Publications (2)

Publication Number Publication Date
FR2799465A1 FR2799465A1 (fr) 2001-04-13
FR2799465B1 true FR2799465B1 (fr) 2004-02-13

Family

ID=9550838

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9912714A Expired - Fee Related FR2799465B1 (fr) 1999-10-12 1999-10-12 Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire

Country Status (7)

Country Link
US (1) US6932973B2 (fr)
EP (1) EP1222201A2 (fr)
JP (1) JP2004502636A (fr)
AU (1) AU7795500A (fr)
CA (1) CA2387604A1 (fr)
FR (1) FR2799465B1 (fr)
WO (1) WO2001027136A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0026134D0 (en) * 2000-10-25 2000-12-13 Eurogene Ltd Peptides and their use
CA2472381C (fr) * 2002-01-09 2014-04-29 Suntory Limited Glycosyltransferase gn-t presentant un effet sur la neovascularisation
FR2846659B1 (fr) 2002-10-30 2005-02-18 Centre Nat Rech Scient Fragments peptidiques du facteur harp inhibant l'angiogenese
DE10355559A1 (de) * 2003-11-21 2005-06-23 Orthogen Ag Transskin
CA2637216A1 (fr) * 2006-02-10 2007-08-16 Dermagen Ab Nouveaux peptides antimicrobiens et leur utilisation
PL2280720T3 (pl) 2008-03-27 2019-07-31 Purdue Research Foundation Syntetyczne peptydoglikany wiążące kolagen, otrzymywanie oraz sposoby zastosowania
WO2009153418A1 (fr) * 2008-06-16 2009-12-23 Centre National De La Recherche Scientifique (C.N.R.S) Peptides harp inhibant la croissance tumorale
WO2011115562A1 (fr) * 2010-03-18 2011-09-22 Egesten Medical Consulting Hb Composé antimicrobien
FR2957799B1 (fr) * 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
SG195114A1 (en) 2011-05-24 2013-12-30 Purdue Research Foundation Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
EP2970509B1 (fr) 2013-03-15 2020-05-13 Purdue Research Foundation Peptidoglycanes synthétiques de liaison à la matrice extracellulaire
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
EP3648774A4 (fr) 2017-07-07 2021-04-21 Symic IP, LLC Bioconjugués synthétiques
CN117244043B (zh) * 2023-11-02 2024-09-20 徐州医科大学附属医院 破伤风类毒素在治疗血管内皮细胞损伤中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294322B1 (en) * 1988-01-26 2001-09-25 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1
HUT62658A (en) * 1990-03-21 1993-05-28 Isis Pharmaceuticals Inc Reagent and process for modifying expression of gene by imitating rna
FR2665448A1 (fr) * 1990-08-01 1992-02-07 Paris Val De Marne Universite Procede d'obtention d'un peptide ayant une activite facteur de croissance, produit obtenu et son application comme medicament.
US6022541A (en) * 1991-10-18 2000-02-08 Beth Israel Deaconess Medical Center Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel
FR2701955B1 (fr) * 1993-02-26 1995-05-24 Paris Val Marne Universite Facteur de croissance de la famille de l'HARP, procédé d'obtention et applications.
ATE228529T1 (de) * 1996-08-30 2002-12-15 Jens Peter Fuerste Spiegelselektion und spiegelevolution von nucleinsäuren
JP2001509168A (ja) * 1997-01-29 2001-07-10 コーネル リサーチ ファウンデーション、インコーポレイティッド 血管新生を誘導するためのアデノウイルスベクターの多部位送達

Also Published As

Publication number Publication date
AU7795500A (en) 2001-04-23
FR2799465A1 (fr) 2001-04-13
WO2001027136A3 (fr) 2001-12-13
CA2387604A1 (fr) 2001-04-19
JP2004502636A (ja) 2004-01-29
US20030087255A1 (en) 2003-05-08
US6932973B2 (en) 2005-08-23
EP1222201A2 (fr) 2002-07-17
WO2001027136A2 (fr) 2001-04-19

Similar Documents

Publication Publication Date Title
FR2799465B1 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
ID28111A (id) Metoda untuk meningkatkan kesehatan kulit
FR2790967B1 (fr) Systeme de stimulation cardiaque
DE69825566D1 (de) Implantierbarer herzschrittmacher
DE69824170D1 (de) Ratenstabilisierender herzschrittmacher
DK1031346T3 (da) Ikke-invasiv vaccination gennem huden
IT1291822B1 (it) Sistema per la defibrillazione elettrica cardiaca impiantabile con attenuazione del dolore derivante dallo shock elettrico mediante
DE69832639D1 (de) Implantierbares Herzschrittmachersystem
EP1231836A4 (fr) Systeme immunitaire humain ex vivo
DE69832229D1 (de) Herzschrittmachersystem mit verbesserter Erkennung der evozierten Reaktion und des Repolarisationssignals
FR2759366B1 (fr) Composes constituant notamment des effecteurs de recepteurs du systeme nerveux central sensibles aux amino acides neuroexcitateurs, leur preparation et leurs applications biologiques
DE69633211D1 (de) Implantierbare Herzstimulationseinrichtung
DE69829554D1 (de) Ovalgefortme herzkanüle
ID26725A (id) Zat untuk mencegah dan mengobati penyakit-penyakit kulit
DE69723899D1 (de) Taktempfindlicher Herzschrittmacher
HUP0100285A3 (en) Use of protein kinase c inhibitors to enhance the the clinical efficacy of oncolytic agents and radiation therapy
DE69722952D1 (de) Sprühgetrocknete mikropartikel als therapeutische träger
DE60105989D1 (de) Implantierbarer herzstimulator
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
FI962813A0 (fi) IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen
DE69929192D1 (de) Herzstimulator mit bestimmung des stimulationsschwellwertes
DE19781819T1 (de) Kardiale Schrittmacher-Anschlußvorrichtung
ID24060A (id) Pengolahan kulit hewan yang ditingkatkan
NO995231D0 (no) Terapeutisk behandling av hudlidelser
DE69837507D1 (de) Humanes Hedgehog-Protein

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110630